Dear Friends, Here is more on intradermal Influenza vaccine: http://www.ncbi.nlm.nih.gov/pubmed/18652550
http://content.nejm.org/cgi/content/full/351/22/2286 The government of India is importing 2.8 million doses of H1N1 vaccine, but it can come down to 0.7-0.8 million doses if they try for the intradermal route for this influenza vaccine. Five times the saving! Is there anyone listening? Regards,
Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)Directorate of Health Safety and Regulation,
Himachal Pradesh+91-9418120302[[email protected]][email protected][/email]; [email protected]
Dear Sir, Thanks for the mail. Actually we need to do simultaneous trials for intradermal delivery of H1N1 vaccine to spare the vaccine and save the money as well. There is more to it, please refer to the link below, http://www.ncbi.nlm.nih.gov/pubmed/15525714?ordinalpos=1&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_Discovery_RA&linkpos=2&log$=relatedarticles&logdbfrom=pubmed Let some one do the trials, but the evidence is supportive the the Intradermal vaccine is not only dose sparing but effective as well,Regards,
Dr. Omesh BhartiM.B.B.S.,D.H.M.,M.A.E.(Epidemiology)
Directorate of Health Safety and Regulation,Himachal Pradesh+91-9418120302
[[email protected]][email protected][/email]; [email protected]
--- On Mon, 28/9/09, julian wrote:
- Page :
- 1
There are no replies made for this post yet.